Exciting new pilot study: tDCS + online cognitive training over 2 weeks improves cognitive function, emotional regulation, and overall functioning in adults with BPD. Non-invasive #BrainStimulation meets digital therapy! ⚡🧠 #BPD #tDCS #MentalHealth doi.org/10.1503/jpn....

#Benzodiazepine use in the third trimester is linked to higher risks of preterm #birth (OR 1.71) and small-for-gestational-age #infants (OR 1.47), but first and second trimester exposure appears safer. Timing matters! ⏳👶 #Pregnancy #MaternalHealth #Benzodiazepines

Women earn half of PhDs but face faculty underrepresentation. Memorial University, Newfoundland and Labrador took action. Four years later, women offered positions rose from 20% to 80%. Read more on our #CSPBlog 👩‍🔬▶️ https://ow.ly/iNgr50XmxbN #EquityInAction #DiversityInSTEM

New approach for schizophrenia: a patient with severe metabolic issues and neuromotor side effects from standard #antipsychotics improved on xanomeline–trospium, a muscarinic M1/M4 agonist. Symptoms improved—without weight gain or motor side effects. 💊 #Schizophrenia doi.org/10.1503/jpn....

Can #psychedelics safely help people with #schizophrenia spectrum disorders? A case study shows #psilocybin-assisted therapy reduced negative and depressive symptoms in a patient on #antipsychotics, with benefits lasting months and no psychotic relapse. 💊🌀 #Schizoaffective

#Weight loss can affect #clozapine levels in patients with treatment-resistant #schizophrenia 📉 New case shows substantial decrease in drug levels with lifestyle changes and semaglutide use—highlighting the importance of therapeutic drug monitoring. #Clozapine #GLP1 #Ozempic doi.org/10.1503/jpn....

Gradual #SRI discontinuation can be tricky with limited dosing options. How can we leverage a fluoxetine-based approach to make the process smoother and safer for #patients. 💊 #Psychiatry #Fluoxetine #MedicationManagement doi.org/10.1503/jpn....

This #OpenAccess Week, check out all the #CSPBlogs on open access! We share a whole range of perspectives on community-driven publishing and making trusted science accessible to everyone. 🔓▶️https://buff.ly/tmdgaTd

Happy #OAWeek! Discover our #OpenAccess partnerships and see if your institution has an agreement with us for options with reduced fees. We're committed to advancing open access for all researchers ▶️https://buff.ly/wXyNuKG

Our publisher @cdnsciencepub.com has spent 15+ years expanding open access options to make research more accessible to everyone. In our latest blog @ecolevol.bsky.social explains why there’s no one-size-fits-all approach to OA. Read more ▶️ buff.ly/utW3mcV #CSPBlog #YourResearchHome

Celebrate #OAWeek by exploring our #OpenAccess Glossary! Learn key terms in scholarly publishing and OA. The glossary is regularly updated with new definitions to keep you informed 🔓▶️https://buff.ly/vY52QED

Academic freedom is essential to strong science. Our CEO and Executive Editor-in-Chief Robert Mann share how we protect editorial independence, support diverse voices, and uphold rigorous peer review 🍁▶️ buff.ly/Ays4Y8I #YourResearchHome #AcademicFreedom @elainestott.bsky.social

How do biological contributors influence depression, anxiety, or addiction in women? The Journal of Psychiatry & Neuroscience publishes research that explores these complex links. Read the latest ➡️ buff.ly/shEN307 #MentalHealthResearch #Psychiatry #Neuroscience

🧠 Calling all clinicians! Journal of Psychiatry & Neuroscience is seeking case studies that shed light on mental health diagnosis and treatment. Help advance clinical practice—publish Open Access, free of charge! cdnsciencepub.com/jpn #Psychiatry #MentalHealth #Neuroscience #OpenAccess

Today, on the National Day for Truth and Reconciliation, we reflect on the resilience and wisdom of Indigenous Peoples. May we listen, learn, and walk together toward a more inclusive future. #TruthAndReconciliation #IndigenousPeoples #Equity

⚡ Can brain stimulation improve ADHD symptoms in kids? A meta-analysis finds tDCS enhances attention and inhibitory control, but not overall clinical symptoms. 👉 doi.org/10.1503/jpn.... #ADHDResearch #Neurostimulation #tDCS

Why do past traumas increase risky cannabis use? 🤔 Altered striatal–cortical circuits may potentiate craving after trauma, while cannabis cues activate corticolimbic pathways. 👉 doi.org/10.1503/jpn.... #Neuroimaging #CannabisUse #MentalHealthResearch

🧠 How are elevated BDNF levels linked to #autism? New #research shows that in children with ASD, increased peripheral BDNF is associated with oxidative stress—and reversing it in mice rescues autism-like behaviors. 👉 doi.org/10.1503/jpn.... #AutismResearch #Neurodevelopment #BDNF

This study moves beyond brain regions to explore how obsessive–compulsive disorder may be rooted in broader brain network disruptions. Learn more ➡️https://buff.ly/be859Sw #PsychiatryResearch #Neuroscience #OCDResearch 📸jpn.240145-fig1

🧠 How do brain blood flow and white matter structure interact in youth with bipolar disorder? New research finds ACC blood flow is linked to cingulum white matter integrity—especially in asymptomatic females. 👉 doi.org/10.1503/jpn.... #Neuroimaging #BipolarDisorder #YouthMentalHealth

Celebrate #PeerReviewWeek with us! This week highlights the essential role of reviewers in scholarly publishing. Learn how you can contribute through peer review 📖▶️ buff.ly/aG0O0C2 #PRW2025

We’re in Montréal at the CCNP 47th Annual Meeting. Stop by and connect with Journal of Psychiatry & Neuroscience! #MentalHealthResearch #Neuropsychopharmacology #CCNP2025

Could psychedelics offer relief from depressive and negative symptoms in schizoaffective disorders? New to @cdnsciencepub.com's portfolio, JPN brings new insight into this connection through original research, reviews, and more ➡️ buff.ly/V23qEJS 📸 jpn.250005-fig1

Heading to Montréal for the CCNP 47th Annual Meeting? Come visit us! We’re excited to connect with researchers and colleagues. #MentalHealthResearch #Neuropsychopharmacology #CCNP2025

📊 How real is the youth mental health crisis? A new editorial examines national & provincial trends in symptoms, suicidality, and healthcare use — and explores why interpreting these numbers is more complex than it seems. 👉 doi.org/10.1503/jpn.... #YouthMentalHealth #PublicHealth #SuicidePrevention

We are thrilled to be attending the Canadian College of Neuropsychopharmacology 47th Annual Meeting in Montréal from September 17–19! We can't wait to connect with the amazing community. Come say hi! #MentalHealthResearch #Neuropsychopharmacology #CCNP2025

@jpnjournal.bsky.social publishes work that helps us understand the brain processes behind psychiatric disorders. Sign-up to our newsletter by selecting the Journal of Psychiatry and Neuroscience as your journal preference! ➡️ buff.ly/jOJA1zh #PsychSciSky #Neuroscience #Neuroskyence

Explore Canada’s youth mental health crisis: rising distress, social media impact, and barriers to care. Read more in @jpnjournal.bsky.social ▶️ cdnsciencepub.com/doi/full/10.... #YouthMentalHealth #MentalHealthCanada #MentalHealthAwareness

We’ve joined a new publisher! Excited to partner with @cdnsciencepub.com as we continue publishing leading research in brain and mental health science. Learn more ➡️ buff.ly/RnlFsYt #AcademicSky #SciComm 🧪 #PHDSky #PsychSciSky #Neuroscience #Neuroskyence

Prematurity and low birth weight with prenatal benzodiazepine exposure: Benzodiazepine exposure in the third trimester is linked to increased risk of preterm and small-for-gestational-age births. ➡️https://doi.org/10.1503/jpn.240063

Cognitive training and tDCS for borderline personality disorder: A combined approach was well tolerated and showed improvements in cognitive performance, symptoms, and functioning. ➡️https://doi.org/10.1503/jpn.250041

Risks of prematurity and low birth weight associated with trimester-specific prenatal benzodiazepine exposure. New articles on prenatal benzodiazepine exposure and borderline personality disorder. ➡️https://www.jpn.ca/content/50/4

Childhood trauma and HDM in psychosis: Do alterations in hippocampal-dependent memory underlie the relationship between developmental trauma and psychosis? ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.240150

Weight loss and clozapine levels: Given the recent surge in use of GLP-1 agonists, it is likely that more patients taking clozapine may experience weight loss and worsening of schizophrenia symptoms. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250076

Youth mental health in Canada: Mental health professionals have the obligation to listen to youth and to develop clinical, evidence-based programs and research initiatives to support their needs. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250115

Are the kids alright? Making sense of the current youth mental health crisis in Canada through heuristics and data. New articles on youth mental health, weight loss and clozapine, and childhood trauma. ➡️https://www.jpn.ca/content/50/4

Transcranial direct current stimulation for ADHD: Stimulation may improve the attention and inhibitory abilities in ADHD, particularly with optimal stimulation parameters. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250032

Trauma and cannabis cue–induced functional connectivity: Trauma- and cannabis-related cues may potentiate cannabis craving through altered reward circuit functional connectivity. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250064

Trauma and cannabis cue–induced reward circuit functional connectivity in cannabis users with trauma histories. New articles on cannabis use with trauma history and ADHD. ➡️https://www.jpn.ca/content/50/4

Serotoninergic psychedelics for schizoaffective disorders: Psilocybin-assisted therapy reduced depressive and negative symptoms without worsening psychosis in a patient with schizoaffective disorder. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250005

BDNF and oxidative stress in autism: Elevated BDNF in autism is linked to oxidative stress; reversing the redox imbalance in mice normalizes BDNF and improves autism-like behaviours. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250087

Cerebral blood flow and white matter integrity in youth bipolar disorder: Vascular health may be related to the preservation of white matter microstructure early in bipolar disorder. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250019

Serotoninergic psychedelics for schizoaffective disorders. New articles on psilocybin-assisted therapy, BDNF and oxidative stress in autism, and youth bipolar disorder. ➡️https://www.jpn.ca/content/50/4

Fluoxetine substitution for deprescribing antidepressants: A novel fluoxetine substitution protocol offers a safe, practical way to taper SRIs while minimizing risk of withdrawal symptoms. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250054

Switching to a muscarinic agonist: Xanomeline–trospium can alleviate metabolic and neuromotor adverse effects from previous antipsychotic treatment while improving the symptoms of schizophrenia. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250022

Fluoxetine substitution for deprescribing antidepressants: a technical approach. New articles on alleviating adverse effects in schizophrenia, and a safe and practical way to taper SRIs. ➡️https://www.jpn.ca/content/50/4

Decriminalization or more treatment? Recent evidence suggests that the overdose crisis is better addressed by increased treatment access than poorly implemented decriminalization programs. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250084

The manicogenic properties of clozapine: This patient's case highlights a rare case of manic switch and proposes plausible mechanisms of clozapine-induced hypomania. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250048

Familial risk of mood disorders and brain functional connectivity: Connectivity within and between the DMN, CEN, and SN is not a neural indicator of familial risk for major mood disorders. ➡️http://www.jpn.ca/lookup/doi/10.1503/jpn.250002

The manicogenic properties of clozapine: a rare but serious potential adverse effect. New articles on manicogenic properties of clozapine, and familial risk of mood disorders and brain functional connectivity. ➡️https://www.jpn.ca/content/50/3